Literature DB >> 17600529

Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment.

Mary M Kavurma1, Nichola Figg, Martin R Bennett, John Mercer, Levon M Khachigian, Trevor D Littlewood.   

Abstract

Apoptosis of VSMCs (vascular smooth-muscle cells) leads to features of atherosclerotic plaque instability. We have demonstrated previously that plaque-derived VSMCs have reduced IGF1 (insulin-like growth factor 1) signalling, resulting from a decrease in the expression of IGF1R (IGF1 receptor) compared with normal aortic VSMCs [Patel, Zhang, Siddle, Soos, Goddard, Weissberg and Bennett (2001) Circ. Res. 88, 895-902]. In the present study, we show that apoptosis induced by oxidative stress is inhibited by ectopic expression of IGF1R. Oxidative stress repressed IGF1R expression at multiple levels, and this was also blocked by mutant p53. Oxidative stress also induced p53 phosphorylation and apoptosis in VSMCs. p53 negatively regulated IGF1R promoter activity and expression and, consistent with this, p53-/- VSMCs demonstrated increased IGF1R expression, both in vitro and in advanced atherosclerotic plaques in vivo. Oxidative-stress-induced interaction of endogenous p53 with TBP (TATA-box-binding protein) was dependent on p53 phosphorylation. Oxidative stress also increased the association of p53 with HDAC1 (histone deacetylase 1). Trichostatin A, a specific HDAC inhibitor, or p300 overexpression relieved the repression of IGF1R following oxidative stress. Furthermore, acetylated histone-4 association with the IGF1R promoter was reduced in cells subjected to oxidative stress. These results suggest that oxidative-stress-induced repression of IGF1R is mediated by the association of phosphorylated p53 with the IGF1R promoter via TBP, and by the subsequent recruitment of chromatin-modifying proteins, such as HDAC1, to the IGF1R promoter-TBP-p53 complex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17600529      PMCID: PMC2267398          DOI: 10.1042/BJ20070380

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Efficient expression of exogenous genes in primary vascular cells using IRES-based retroviral vectors.

Authors:  Kyle J Garton; Nicola Ferri; Elaine W Raines
Journal:  Biotechniques       Date:  2002-04       Impact factor: 1.993

Review 2.  Control of cell survival by IGF signaling pathways.

Authors:  Andrea M Vincent; Eva L Feldman
Journal:  Growth Horm IGF Res       Date:  2002-08       Impact factor: 2.372

3.  Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice.

Authors:  B J van Vlijmen; G Gerritsen; A L Franken; L S Boesten; M M Kockx; M J Gijbels; M P Vierboom; M van Eck; B van De Water; T J van Berkel; L M Havekes
Journal:  Circ Res       Date:  2001-04-27       Impact factor: 17.367

4.  NF1/X represses PDGF A-chain transcription by interacting with Sp1 and antagonizing Sp1 occupancy of the promoter.

Authors:  Louise A Rafty; Fernando S Santiago; Levon M Khachigian
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

5.  Histone deacetylases specifically down-regulate p53-dependent gene activation.

Authors:  L J Juan; W J Shia; M H Chen; W M Yang; E Seto; Y S Lin; C W Wu
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

6.  Thrombin regulates insulin-like growth factor-1 receptor transcription in vascular smooth muscle: characterization of the signaling pathway.

Authors:  J Du; M Brink; T Peng; B Mottironi; P Delafontaine
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

Review 7.  IGF-I receptor signalling in transformation and differentiation.

Authors:  B Valentinis; R Baserga
Journal:  Mol Pathol       Date:  2001-06

8.  Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling.

Authors:  V A Patel; Q J Zhang; K Siddle; M A Soos; M Goddard; P L Weissberg; M R Bennett
Journal:  Circ Res       Date:  2001-05-11       Impact factor: 17.367

9.  Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque.

Authors:  Y Okura; M Brink; A A Zahid; A Anwar; P Delafontaine
Journal:  J Mol Cell Cardiol       Date:  2001-10       Impact factor: 5.000

10.  IGFBP-3 mediates p53-induced apoptosis during serum starvation.

Authors:  Adda Grimberg; Bingrong Liu; Peter Bannerman; Wafik S El-Deiry; Pinchas Cohen
Journal:  Int J Oncol       Date:  2002-08       Impact factor: 5.650

View more
  19 in total

1.  Upregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration.

Authors:  Young-Don Kwak; Bin Wang; Jing Jing Li; Ruishan Wang; Qiyue Deng; Shiyong Diao; Yaomin Chen; Raymond Xu; Eliezer Masliah; Huaxi Xu; Jung-Joon Sung; Francesca-Fang Liao
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

Review 2.  Epigenetic regulation of vascular smooth muscle cell function in atherosclerosis.

Authors:  Hannes M Findeisen; Florian K Kahles; Dennis Bruemmer
Journal:  Curr Atheroscler Rep       Date:  2013-05       Impact factor: 5.113

Review 3.  Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?

Authors:  Terry J Smith
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

4.  Advanced glycation end products promote human aortic smooth muscle cell calcification in vitro via activating NF-κB and down-regulating IGF1R expression.

Authors:  Yi Wang; Zhen-yu Zhang; Xiao-qing Chen; Xiang Wang; Heng Cao; Shao-wen Liu
Journal:  Acta Pharmacol Sin       Date:  2013-02-18       Impact factor: 6.150

Review 5.  Epigenetic reprogramming in atherosclerosis.

Authors:  Vincenzo Grimaldi; Maria Teresa Vietri; Concetta Schiano; Antonietta Picascia; Maria Rosaria De Pascale; Carmela Fiorito; Amelia Casamassimi; Claudio Napoli
Journal:  Curr Atheroscler Rep       Date:  2015       Impact factor: 5.113

6.  Developmental programming: Prenatal bisphenol A treatment disrupts mediators of placental function in sheep.

Authors:  Wenhui Song; Muraly Puttabyatappa; Lixia Zeng; Delia Vazquez; Subramaniam Pennathur; Vasantha Padmanabhan
Journal:  Chemosphere       Date:  2019-11-06       Impact factor: 7.086

Review 7.  Antagonistic pleiotropy and p53.

Authors:  Erica Ungewitter; Heidi Scrable
Journal:  Mech Ageing Dev       Date:  2008-07-01       Impact factor: 5.432

Review 8.  NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?

Authors:  Sanghamitra Sahoo; Daniel N Meijles; Patrick J Pagano
Journal:  Clin Sci (Lond)       Date:  2016-03       Impact factor: 6.124

Review 9.  Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?

Authors:  M P Little
Journal:  Mutat Res       Date:  2010-01-25       Impact factor: 2.433

Review 10.  The p53 network: cellular and systemic DNA damage responses in aging and cancer.

Authors:  H Christian Reinhardt; Björn Schumacher
Journal:  Trends Genet       Date:  2012-01-20       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.